These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9383008)

  • 61. Functional development of dopamine receptors in the rat forebrain.
    Ormond DL; Van Hartesveldt C
    Pharmacol Biochem Behav; 1979 Jun; 10(6):855-60. PubMed ID: 573475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat.
    Maldonado-Irizarry CS; Kelley AE
    Brain Res Bull; 1995; 38(6):551-9. PubMed ID: 8590077
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microinjections of a nicotinic agonist into dopamine terminal fields: effects on locomotion.
    Museo E; Wise RA
    Pharmacol Biochem Behav; 1990 Sep; 37(1):113-6. PubMed ID: 2263652
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine.
    Chau D; Rada PV; Kosloff RA; Hoebel BG
    Ann N Y Acad Sci; 1999 Jun; 877():769-74. PubMed ID: 10415702
    [No Abstract]   [Full Text] [Related]  

  • 65. Passive avoidance in rats: disruption by dopamine applied to the nucleus accumbens.
    Bracs PU; Gregory P; Jackson DM
    Psychopharmacology (Berl); 1984; 83(1):70-5. PubMed ID: 6429703
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Locomotor response of nialamide pretreated old rats to intraaccumbens dopamine.
    Cousin KM; Uretsky NJ; Gerald MC
    Pharmacol Biochem Behav; 1985 Mar; 22(3):461-8. PubMed ID: 3991761
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stereotaxic localization of the developing nucleus accumbens septi.
    Philpot RM; McQuown S; Kirstein CL
    Brain Res Dev Brain Res; 2001 Sep; 130(1):149-53. PubMed ID: 11557105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dopamine and thermoregulation: an evaluation with special reference to dopaminergic pathways.
    Lee TF; Mora F; Myers RD
    Neurosci Biobehav Rev; 1985; 9(4):589-98. PubMed ID: 3001601
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cholinergically mediated reduction of locomotor activity from the basal forebrain of the rat.
    Brudzynski SM; McLachlan RS; Girvin JP
    Exp Neurol; 1989 Aug; 105(2):197-205. PubMed ID: 2753117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rotation and postural deviation elicited by microinjections of dopamine into medial and lateral regions of dorsal striatum.
    Joyce JN; van Hartesveldt C
    Pharmacol Biochem Behav; 1984 Dec; 21(6):979-81. PubMed ID: 6522422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential behavioral effects of angiotensin II microinjected unilaterally into the CA1 hippocampal area.
    Belcheva I; Chobanova M; Georgiev V
    Regul Pept; 1998 Jun; 74(2-3):67-71. PubMed ID: 9712165
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intrastriatal injection of [3H]dopamine through a chronic cannula to produce rotation: distribution and concentration of the tracer in specific brain regions.
    Wolfson LI; Brown LL
    Brain Res; 1983 Feb; 261(2):205-12. PubMed ID: 6831208
    [No Abstract]   [Full Text] [Related]  

  • 73. Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens.
    Pijnenburg AJ; van Rossum JM
    J Pharm Pharmacol; 1973 Dec; 25(12):1003-5. PubMed ID: 4150283
    [No Abstract]   [Full Text] [Related]  

  • 74. Serotoninergic modulation of the dopamine response from the nucleus accumbens.
    Costall B; Naylor RJ; Marsden CD; Pycock CJ
    J Pharm Pharmacol; 1976 Jun; 28(6):523-6. PubMed ID: 7657
    [No Abstract]   [Full Text] [Related]  

  • 75. The mechanism by which exercise modifies brain function.
    Sutoo DE; Akiyama K
    Physiol Behav; 1996 Jul; 60(1):177-81. PubMed ID: 8804660
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 14C-dopamine microinjected into the brain-stem of the rat: dispersion kinetics, site content and functional dose.
    Myers RD; Hoch DB
    Brain Res Bull; 1978; 3(6):601-9. PubMed ID: 318183
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intracranial landmarks and other techniques to further improve the precision of stereotaxic tracer injections.
    Kovács ZI; Palkovits M
    Exp Brain Res; 2011 Jan; 208(1):51-60. PubMed ID: 20978749
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variability of bregma in 300 gram Long-Evans and Sprague-Dawley rats.
    Kline J; Reid KH
    Physiol Behav; 1984 Aug; 33(2):301-3. PubMed ID: 6390473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neural underpinnings of the identifiable victim effect: affect shifts preferences for giving.
    Genevsky A; Västfjäll D; Slovic P; Knutson B
    J Neurosci; 2013 Oct; 33(43):17188-96. PubMed ID: 24155323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats.
    Piras G; Cadoni C; Caria F; Pintori N; Spano E; Vanejevs M; Ture A; Tocco G; Simola N; De Luca MA
    Int J Neuropsychopharmacol; 2024 May; 27(5):. PubMed ID: 38546531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.